| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |